Yıkılmaz, A. Ş., Akinci, S., Bakanay, Ş. M., & Dilek, İ. (2020). VAD Chemotherapy versus Bortezomib Containing Regimens as Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience. Int J Hematol Oncol Stem Cell Res.
Citação norma ChicagoYıkılmaz, Aysun Şentürk, Sema Akinci, Şule Mine Bakanay, and İmdat Dilek. "VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience." Int J Hematol Oncol Stem Cell Res 2020.
ציטוט MLAYıkılmaz, Aysun Şentürk, Sema Akinci, Şule Mine Bakanay, and İmdat Dilek. "VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience." Int J Hematol Oncol Stem Cell Res 2020.